4.5 Review

Application of Artificial Intelligence in Drug Discovery

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 28, Issue 33, Pages 2690-2703

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612828666220608141049

Keywords

Artificial intelligence; drug discovery; high-throughput screening; electronic records; molecular docking; machine learning; deep learning

Ask authors/readers for more resources

Modern drug discovery has shifted towards big data, with the help of Artificial intelligence making drug discovery more precise and knowledgeable. Pharmaceutical companies have started a race to find new drugs, with AI predicting compound characteristics, saving time and resources.
Due to the heap of data sets available for drug discovery, modern drug discovery has taken the shape of big data. Usage of Artificial intelligence (AI) can help to modify drug discovery based on big data to precised, knowledgeable data. The pharmaceutical companies have already geared their departments for this and started a race to search for new novel drugs. The AI helps to predict the molecular structure of the compound and its in-vivo vs. in-vitro characteristics without hampering life, thus saving time and economic loss. Clinical studies, electronic records, and images act as a helping hand for the development. The data mining and curation techniques help explore the data with a single click. AI in big data analysis has paved the red carpet for future rational drug development and optimization. This review's objective is to familiarise readers with various advances in the AI field concerning software, firms, and other tools working in easing out the labor of the drug discovery journey.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available